Site Menu
Buscar Close Search
Buscar Close Search

Comprehensive scientific and clinical solutions to address the critical challenge of drug resistance by prioritizing drug design and therapeutic strategies.

 

Our Mission 

Page Menu

  • Medicines Designed to Last

    celia-schiffer-video-thumbnail.jpg

  • Uncovering Pathways to Resistance in cancer

    daniel-bolon-video-thumbnail.jpg

  • Chemo Chainsaw

    sharon-cantor-video-thumbnail.jpg

  • Overcoming Therapeutic Resistance in Pancreatic Cancer

    brian-lewis-video-thumbnail.jpg

  • Designed Biologics as Antivirals to avoid Drug Resistance

    yang-wang-video-thumbnail.jpg

  • Newest Drugs for the Oldest Parasites

    raffi-aroian-video-thumbnail.jpg

  • Thwarting Antibiotic Resistance in Psuedonomas Aerginosa

    pukkila-worley-video-thumbnail.jpg

  • Using Structural Biology to Tackle Antibiotic Resistance

    andrei-korostelev-video-thumbnail.jpg

  • Modifying Bacterial Behavior to Avoid Antibiotic Resistance

    elizabeth-shank-video-thumbnail.jpg

  • How to Discover New Antibiotics by Getting Bacteria to “Talk” to Each Other

    elizabeth-shank-video2-thumbnail.jpg

  • Bacteria Infection of Cancer Tumors – The Hidden Passengers we Ignored for too Long

    amir-mitchell-video-thumbnail.jpg

  • Preventing Antibiotic Resistance by Blocking Evolution

    brian-kelch-video-thumbnail.jpg

Latest News

Getting Results…
  • UMass Chan delivers fitting tribute to young Worcester scholars

    UMass Chan delivers fitting tribute to young Worcester scholars

    UMass Chan presented “scientist-in-training” lab coats to Lake View Elementary School, one of the 11 North Quadrant schools in Worcester that are part of the UMass Chan North Quadrant Support Services Initiative.

    Read more
  • Study co-authored by Jonathan Gerber shows COVID-19 vaccines reduce harmful inflammation

    Study co-authored by Jonathan Gerber shows COVID-19 vaccines reduce harmful inflammation

    Vaccination against COVID-19 was linked to reduced inflammation in response to SARS-CoV-2 infection, according to a paper co-authored by UMass Chan Medical School researcher Jonathan M. Gerber, MD.

    Read more
  • UMass Chan Medical School launches Partner in Microscopy program with Leica Microsystems

    UMass Chan Medical School launches Partner in Microscopy program with Leica Microsystems

    The UMass Chan Medical School light microscopy core facility, Sanderson Center for Optical Experimentation, announced a new collaboration with Leica Microsystems.

    Read more
  • Phillip Zamore, Roger Davis elected to National Academy of Medicine

    Phillip Zamore, Roger Davis elected to National Academy of Medicine

    UMass Chan Medical School scientists Phillip D. Zamore, PhD, and Roger J. Davis, PhD, FRS, were elected to the National Academy of Medicine on Oct. 9 for their distinguished contributions to medicine and health.

    Read more
  • Beth McCormick and Michael Stauff named department chairs

    Beth McCormick and Michael Stauff named department chairs

    Beth A. McCormick, PhD, has been named the new chair of the Department of Microbiology & Physiological Systems (MaPS), and Michael P. Stauff, MD, has been appointed chair of the Department of Orthopedics & Physical Rehabilitation.

    Read more
  • Convocation 2023: Chancellor Collins celebrates symphony of collaboration at UMass Chan

    Convocation 2023: Chancellor Collins celebrates symphony of collaboration at UMass Chan

    Four faculty members were honored with chancellor’s medals and four others were invested as endowed professors at the Convocation and Investiture ceremony at UMass Chan Medical School.

    Read more
  • Convocation events 2023

    UMass Chan celebrates start of new academic year with Convocation week

    The festivities begin on Friday, Sept. 8 with the annual White Coat Ceremony, welcoming the new T.H. Chan School of Medicine students into the medical community.

    Read more
  • PhD candidate to use NIH award to study cell death in cancer patients

    PhD candidate to use NIH award to study cell death in cancer patients

    Nicholas Harper, a PhD candidate in the Interdisciplinary Graduate Program, has received a prestigious award from the National Cancer Institute to study cell death as it relates to cancer therapies.

    Read more
  • Kirschstein award to fund PhD candidate’s research on HTLV-1

    Kirschstein award to fund PhD candidate’s research on HTLV-1

    PhD candidate Sarah Zvornicanin has received an award from the National Institute of Allergy and Infectious Diseases to study HTLV-1, a retrovirus that can cause a type of cancer and a progressive nervous system condition.

    Read more
  • UMass Chan BRIDGE Fund invests nearly $2M in 13 faculty projects

    UMass Chan BRIDGE Fund invests nearly $2M in 13 faculty projects

    The BRIDGE Fund supports critical research milestones for inventions and discoveries that have high potential to change the course of disease and continues to grow, increasing from approximately $1 million per year in 2019 to $3 million in 2024.

    Read more
More News
Showing 1-10 of 61 items
of 7